Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Proteinase K Applications: Genomic DNA Isolation & Troublesh
2026-07-27
Unlock robust genomic DNA isolation and protein hydrolysis workflows with APExBIO's Proteinase K, a broad-spectrum serine protease engineered for contaminant removal and DNA integrity. Learn how protocol optimization and experimental troubleshooting drive reproducible results across molecular biology assays.
-
GSK126 EZH2 Inhibitor: Mechanisms, Applications, and Limits
2026-07-27
GSK126 is a potent, selective EZH2 inhibitor central to cancer epigenetics research. It demonstrates sub-nanomolar affinity and robust selectivity for mutant EZH2, making it crucial for dissecting PRC2 function in oncology. Its validated effects in lymphoma, small cell lung, and ovarian cancer models support its use in both basic and translational studies.
-
hiPSC-Derived Intestinal Organoids Advance CYP2C19 Metabolis
2026-07-26
This study presents a robust, streamlined protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) that accurately model intestinal epithelial function, including CYP2C19-mediated drug metabolism. The findings highlight the model's potential to improve in vitro pharmacokinetic studies and address limitations of traditional cell lines and animal models.
-
GSK-923295: Applied CENP-E Inhibitor Workflows in Cancer Res
2026-07-25
GSK-923295 offers precise control over mitotic arrest and chromosome alignment, making it an essential tool for dissecting cell cycle mechanisms in cancer research. This in-depth guide details experimental workflows, troubleshooting tips, and the latest insights on leveraging this CENP-E inhibitor for robust, interpretable results.
-
Cyanine 5-dCTP in Enzymatic Synthesis: Protocols & Innovatio
2026-07-24
Cyanine 5-dCTP enables high-fidelity, red-fluorescent DNA labeling for advanced enzymatic synthesis workflows. Applied with 3D DNA frameworks, it delivers superior probe sensitivity and precision in PCR, sequencing, and nucleic acid detection—backed by robust protocol guidance and troubleshooting.
-
AMG 487: Selective CXCR3 Antagonist for Macrophage Modulatio
2026-07-24
AMG 487 is a potent, selective CXCR3 antagonist that enables precise modulation of macrophage polarization by inhibiting chemokine binding at nanomolar concentrations. The compound, supplied by APExBIO, demonstrates robust activity in cell migration and inflammation models, with well-characterized metabolic and solubility profiles. Its use supports advanced research in chemokine signaling and acute lung injury.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Leukemia Rese
2026-07-23
Explore how the Annexin V-Cy5/DAPI Apoptosis Kit enables precise apoptosis and necrosis detection in advanced leukemia models. This article offers a deeper, mechanism-driven analysis for researchers seeking robust apoptosis detection solutions.
-
Olive Biophenols Reduce Aβ42 Neurotoxicity in AD Models
2026-07-23
This study demonstrates that olive biophenols, especially oleuropein, verbascoside, and rutin, attenuate amyloid β-peptide (1-42)-induced neurotoxicity in both SH-SY5Y cells and APPswe mice. The findings highlight the promise of natural plant compounds in mitigating key pathological features of Alzheimer's disease and inform assay design for neurodegeneration research.
-
ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR
2026-07-22
This study introduces a combinatorial library of biodegradable lipid nanoparticles engineered for selective mRNA delivery to tumor cells by exploiting elevated reactive oxygen species (ROS) levels. The platform demonstrates improved potency and specificity for blocking mutant RAS signaling, with key implications for the development of targeted mRNA-based cancer therapeutics.
-
Aminopeptidase Inhibition and Angiotensin Activity in Rat Br
2026-07-22
This study unravels how aminopeptidase inhibitors, specifically bestatin and amastatin, modulate angiotensin II and III-evoked neuronal activity in the rat brain. The findings clarify the enzymatic processing required for angiotensin II activation and reveal the importance of aminopeptidase B in neuropeptide regulation, providing insights that inform both neurobiology and broader research into exopeptidase inhibition.
-
Esflurbiprofen and Rapid Antidepressant Action via SERT-nNOS
2026-07-21
The referenced study reveals that esflurbiprofen disrupts the serotonin transporter (SERT) and neuronal nitric oxide synthase (nNOS) interaction in the dorsal raphe nucleus, resulting in rapid-onset antidepressant effects in murine models. This mechanistic insight advances the search for antidepressants with faster therapeutic onset and fewer side effects than current SSRIs.
-
Angiotensin 1/2 (2-7) Peptide: Precision Tools for RAS Resea
2026-07-21
Angiotensin 1/2 (2-7) empowers researchers with a high-purity, versatile vasoconstrictor peptide fragment for advanced modeling of the renin-angiotensin system. Explore how this APExBIO-grade peptide unlocks reproducible workflows in blood pressure, aldosterone signaling, and viral pathogenesis studies.
-
Streptavidin-FITC: Advanced Fluorescent Detection Workflows
2026-07-20
Streptavidin-FITC from APExBIO delivers unmatched sensitivity for biotinylated molecule detection in immunofluorescence, flow cytometry, and nucleic acid tracking. This article provides actionable protocols, troubleshooting insights, and a translational bridge to recent innovations in nanoparticle research.
-
FK866 (APO866): Scenario-Driven Solutions for Cancer Assays
2026-07-20
This article equips biomedical researchers and lab technicians with evidence-based, scenario-driven strategies for deploying FK866 (APO866) (SKU A4381) in hematologic cancer research and cell viability workflows. Drawing on practical lab challenges and validated literature, it emphasizes how APExBIO’s FK866 delivers reproducible, mechanistically precise, and cost-effective solutions in NAD metabolism and acute myeloid leukemia (AML) models.
-
Cyanine 3-dCTP (SKU B8159): Reliable DNA Labeling in Genomic
2026-07-19
This article addresses common workflow and data reliability challenges in fluorescent nucleic acid labeling, focusing on how Cyanine 3-dCTP (SKU B8159) from APExBIO offers robust, high-purity solutions. Scenario-driven Q&A blocks provide practical guidance for PCR, Nick Translation, and in situ hybridization workflows, with quantitative backing and evidence-based vendor selection advice.